Richard Beckman
Net worth: 55 231 $ as of 2024-03-30
Profile
Richard L.
Beckman worked as a Director-Regional Scientific Services at Allergan, Inc., Medical Director at Becton, Dickinson & Co., Chief Medical Officer at ReNeuron Group Plc, Senior Vice President-Development at Lux Biosciences, Inc., and Chief Medical Officer at Danube Pharmaceuticals, Inc. He also held the position of Vice President-Research & Development at Alcon Laboratories, Inc. Beckman served as Chief Medical Officer at Neurotech Pharmaceuticals, Inc., IVERIC bio, Inc., and Clearside Biomedical, Inc. He will also serve as Chief Medical Officer at Adverum Biotechnologies, Inc. in 2022-2023.
Beckman received his undergraduate and doctorate degrees from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-03-31 | 3,906 ( 0.02% ) | 55 231 $ | 2024-03-30 |
Former positions of Richard Beckman
| Companies | Position | End |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2023-05-31 |
| CLEARSIDE BIOMEDICAL, INC. | Chief Tech/Sci/R&D Officer | 2017-11-30 |
| UNILIFE CORP | Chief Tech/Sci/R&D Officer | 2016-02-29 |
| IVERIC BIO, INC. | Chief Tech/Sci/R&D Officer | 2015-02-28 |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Chief Tech/Sci/R&D Officer | 2013-05-31 |
Training of Richard Beckman
| University of Michigan | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| RENEURON GROUP PLC | Health Technology |
| CLEARSIDE BIOMEDICAL, INC. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Health Technology |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Health Technology |
Unilife Corp.
 Unilife Corp. Medical SpecialtiesHealth Technology Unilife Corp. designs, develops, manufactures and supplies injectable drug delivery systems. The company builds long-term collaborations with pharmaceutical and biotechnology companies seeking to utilize its devices to enable or enhance the clinical development, regulatory approval and lifecycle management of injectable therapies. The company was founded by Alan D. Shortall in 2001 and is headquartered in York, PA. | Health Technology |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Stock Market
- Insiders
- Richard Beckman
